Inventiva (IVA) Change in Acquisitions & Divestments (2020 - 2025)

Inventiva's (IVA) quarterly Change in Acquisitions & Divestments came in at -$28.0 million in Q2 2025, down 206.64% quarter-over-quarter from $26.3 million in Q4 2024.

Inventiva (IVA) Change in Acquisitions & Divestments (2020 - 2025) Analysis & Trends

Inventiva's Change in Acquisitions & Divestments history runs 6 years deep, the most recent figure standing at -$28.0 million for Q2 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to -$28.0 million in Q2 2025; TTM through Jun 2025 was -$14.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$154.6 million, down 688.68% from the prior year.
  • Change in Acquisitions & Divestments slipped to -$28.0 million in Q2 2025 per IVA's latest filing, from $26.3 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $26.3 million in Q4 2024 and bottomed at -$28.0 million in Q2 2025.
  • The 5-year median for Change in Acquisitions & Divestments is $1.1 million (2023), against an average of $2.9 million.
  • Across the five-year window, Change in Acquisitions & Divestments plunged 92.96% in 2023 and soared 34771.75% in 2024, its largest moves.
  • Year by year, Change in Acquisitions & Divestments stood at $6.7 million in 2021, then plunged by 84.14% to $1.1 million in 2022, then plunged by 92.96% to $75315.8 in 2023, then surged by 34771.75% to $26.3 million in 2024, then tumbled by 206.64% to -$28.0 million in 2025.
  • Per Business Quant, the three latest IVA Change in Acquisitions & Divestments figures stand at -$28.0 million (Q2 2025), $26.3 million (Q4 2024), and $75315.8 (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,200.25 Bn 66,199.96 Bn -
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 471.75 Bn 466.96 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.94 Bn 114.69 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.87 Bn 61.12 Bn 3.31 Bn
7 Belite Bio 62.43 Bn 62.43 Bn -
8 Argenx Se 55.86 Bn 50.68 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn
10 Inventiva 846.21 Mn 846.21 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 -28.01 Mn
Jun 30, 2025 -28.01 Mn
Dec 31, 2024 26.26 Mn
Dec 31, 2024 26.26 Mn
Dec 31, 2023 75,315.79
Dec 31, 2023 75,315.79
Jun 30, 2023 1.14 Mn
Jun 30, 2023 1.14 Mn
Dec 31, 2022 1.07 Mn
Dec 31, 2022 1.07 Mn
Jun 30, 2022 11.47 Mn
Jun 30, 2022 11.47 Mn
Dec 31, 2021 6.74 Mn
Dec 31, 2021 6.74 Mn
Jun 30, 2021 -1.89 Mn
Jun 30, 2021 -1.89 Mn
Mar 31, 2021 9.00 Mn
Mar 31, 2021 9.00 Mn
Dec 31, 2020 8.75 Mn
Dec 31, 2020 8.75 Mn